XT
FENC icon

XTX Topco’s Fennec Pharmaceuticals FENC Stock Holding History

XTX Topco’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.8K Sell
15,255
-11,531
-43% -$89K ﹤0.01% 3122
2025
Q4 		$206K Buy
26,786
+5,539
+26% +$45.5K 0.01% 2377
2025
Q3 		$199K Buy
+21,247
New +$184K 0.01% 1852

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

XTX Topco's FENC Position: Q1 2026 in Review

XTX Topco reduced its Fennec Pharmaceuticals (FENC) stake by 43% in Q1 2026, selling an estimated $89K and leaving 15,255 shares worth $93.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3122.

XTX Topco first reported a position in FENC in Q3 2025 and has held it in 3 quarters since. The position peaked at $206K in Q4 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • XTX Topco held 15,255 shares of Fennec Pharmaceuticals worth $93.8K as of Q1 2026.
  • XTX Topco sold 11,531 Fennec Pharmaceuticals shares in Q1 2026, an estimated $89K.
  • Fennec Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3122 holding.
  • XTX Topco first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • XTX Topco's Fennec Pharmaceuticals position peaked at $206K in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.